baber/WOPTO huggingface dataset:
Patent DK-2164794-T3 (DK)
Inventor: RIIS KEN
IPC: B67D1/08
Filed: 2008-04-17
Granted: 2011-05-30
Abstract: The present invention relates to a sealing device (1) for mounting in a fluid passage (7) of a connection piece (5) such as beer extractor tube for a beer keg (13) characterised in that the sealing device (1) is adapted to be permanently-deformed when it is removed from said fluid passage (7).
Patent DK-2112161-T3 (DK)
Inventor: LARSEN BJARNE DUE
IPC: C07K14/575
Filed: 2000-07-12
Granted: 2015-01-19
Abstract: The present invention relates to novel peptide conjugates which have increased stability and are useful in the treatment of excess levels of blood glucose.
Patent DK-2260530-T3 (DK)
Inventor: ZERFASS HANS-RAINER
IPC: B23K1/00
Filed: 2009-02-18
Granted: 2012-05-07
Abstract: Disclosed is a sealing assembly for metal components, wherein the sealing assembly has an electrical insulating effect, and wherein the sealing assembly comprises a ceramic layer and a base brazing material disposed thereon, to which germanium is added. The addition of germanium advantageously ranges from 0.1 to 5.0 mol %, and preferably between 0.5 and 2.5 mol %. A particular embodiment provides for the use of a brazing material which additionally comprises silicon in the range of >0 to 2.5 mol %, and preferably between 0.1 and 0.9 mol %. Furthermore, a brazing material having a further addition of 10 to 40% by volume of Al2TiO5, and preferably between 20 and 30% by volume of Al2TiO5, has proven to be particularly suited for the sealing assembly. The use of the special brazing material composition inside the sealing assembly generally results in reproducibly tight and insulating joints having the following properties: a) escape of brazing material is prevented and running of brazing material is reduced, b) the porosity of the brazing material (primarily individual pores or narrow pore lines) is markedly reduced, c) the brazed joints have sufficient electrical resistance, and d) the brazed joints are generally sufficiently gas-tight (leakage rate during He leakage test <10−3 mbar*1*s−1).
Patent DK-2815753-T3 (DK)
Inventor: OHNISHI YOSHITO
IPC: A61P43/00
Filed: 2013-02-14
Granted: 2018-08-13
Abstract: Provided is an FTD- and TPI-containing oral pharmaceutical composition which can be orally administered and is stable even under high humidity conditions. This oral pharmaceutical composition contains alpha,alpha,alpha-trifluorothymidine and 5-chloro-6-(2-iminopyrrolidine-1-yl) methyl-2,4 (1H, 3H)-pyrimidine dione hydrochloride as the active ingredient, and contains, as an excipient, an additive having an 85% or greater critical relative humidity at 25°C.
Patent DK-3194671-T3 (DK)
Inventor: MARNAS STÉPHANE
IPC: F16K31/34
Filed: 2015-07-10
Granted: 2018-07-16
Abstract: The invention relates to a filling valve (1) for a toilet cistern, which comprises: (i) a body (6) in which there is formed a chamber (20) that has an upstream orifice (21) designed to be connected to a water inlet pipe (2), and a downstream orifice (22) designed to be connected to a pipe (4) for filling a toilet cistern, (ii) a piston (30) comprising a head (32) and a rod, designed to be moved between an open position in which the head (32) of the piston (30) allows a liquid to flow through the downstream orifice (22) and a closed position in which the head (32) of the piston (30) closes off the downstream orifice (22) in a sealed manner. In addition, the head (32) of the piston (30) has at least one undercut region (38) designed to allow the exertion of a hydraulic counter-pressure that assists the piston (30) to pass into its closed position. An elastomeric diaphragm (40) is positioned in the chamber (20) and covers the head (32) of the piston (30) and an annular cavity (34) in order to seal the closure of the downstream orifice (22) by the head (32) of the piston (30).
Patent DK-0431711-T3 (DK)
Inventor: LOECK KARSTEN ING
IPC: C25D13/14
Filed: 1990-11-15
Granted: 1993-12-13
Abstract: The invention relates to a process and an apparatus for anodic or cathodic painting of hollow bodies, particularly cans such as drink cans or the like, using a water-soluble paint as electrolyte liquid. The latter is in contact with the cathode or anode and is fed in at least one uninterrupted jet, which produces a conducting connection, to the surfaces of the hollow body which form the anode or cathode. 
<??>In order to be able to coat hollow bodies in large numbers per unit time with such a process, the invention proposes that the hollow bodies (1) are pushed with the opening (3) down over an electrically conducting grid (4), the paint being flooded in or over the hollow bodies in jets rising up through the free spaces between the grid or grating rods from below and the entire inside and outside surface of the hollow bodies being covered with a continuous layer in the process. 
<IMAGE>
Patent DK-0398487-T3 (DK)
Inventor: BUSCALL RICHARD
IPC: C09K23/52
Filed: 1990-04-06
Granted: 1994-05-02
Abstract: A dispersion of solid inorganic particles in an aqueous medium which is stable to a range of pH's and added electrolyte wherein the dispersing agent is a water soluble copolymer derivable from a hydrophilic oligomer and certain defined olefinically unsaturated acids.
Patent DK-0427402-T3 (DK)
Inventor: UENO RYUJI
IPC: A61P43/00
Filed: 1990-10-11
Granted: 1993-08-16
Abstract: A use of a cyclodextrin or a derivative thereof for the manufacture of a medicament for treatment of shock.
Patent DK-0426368-T3 (DK)
Inventor: HIGHAM PAUL A
IPC: A61L31/00
Filed: 1990-10-24
Granted: 1995-03-13
Abstract: The invention comprises polymer compositions containing cross-linked biodegradable derivatives of chitin for use in preventing adhesion between body tissues.
Patent DK-0403398-T3 (DK)
Inventor: HART TERANCE WILLIAM
IPC: C07D237/08
Filed: 1990-06-15
Granted: 1995-05-15
Abstract: A thioformamide derivative of the formula: <CHEM> wherein R represents alkyl, A represents optionally substituted pyrid-3-yl, isoquinolin-4-yl, tetrahydroquinolin-3-yl, quinolin-3-yl, pyridazin-4-yl, pyrimid-5-yl, thiazol-5-yl, thienoÄ2,3-bÜpyridin-5-yl, pyrazin-2-yl, indol-3-yl, thienoÄ3,2-bÜpyridin-6-yl, or phenyl and Y represents a valency bond, methylene or ethylene, R<2> represents hydrogen, optionally substituted alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryloxyalkyl, aromatic heterocyclylalkyl or aromatic heterocyclyloxyalkyl group or a group BC(=O)- or BSO2 - in which B represents optionally substituted alkyl, aryl, or aromatic heterocyclic, n represents 0 or 1, and when n represents 0 R<1> may represent a hydrogen atom, optionally substituted alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryloxyalkyl, aromatic heterocyclylalkyl or aromatic heterocyclyloxyalkyl group or a group BC(=O)-, and when n represents 1 R<1> represents optionally substituted alkyl, benzyl, phenethyl, 1-naphthylmethyl, 2-naphthylmethyl or pyrid-3-ylmethyl radical and pharmaceutically acceptable salts thereof possess pharmacological properties.
Patent DK-0482087-T3 (DK)
Inventor: KUEMMEL DIETMAR
IPC: G04F10/04
Filed: 1990-07-13
Granted: 1993-05-24
Abstract: PCT No. PCT/EP90/01150 Sec. 371 Date Feb. 21, 1992 Sec. 102(e) Date Feb. 21, 1992 PCT Filed Jul. 13, 1990 PCT Pub. No. WO91/01535 PCT Pub. Date Feb. 7, 1991.A medical apparatus to be worn in the mouth comprises a battery-fed measuring unit (15) including a clock generator (18) and a counter (20) for counting the pulses of the clock generator. Accuracy of the time measurement decisively depends on the precision of the oscillating frequency of the clock generator. In the invention, there is used a clock generator (18) wherein frequency precision is low. When the counted value of the counter (20) is read into an external evaluating unit, the measuring unit supplies a reference time required by the clock generator (18) for generating a number of pulses. The evaluating unit calculates the time corresponding to the counted value under consideration of the length of the reference time. Thus, the evaluating unit measures the cycle length of the pulses of the clock generator, and this cycle length is multiplied by the number of the counted clock pulses. In this manner, time measurement is performed in a precise manner without requiring a highly precise clock generator.
Patent DK-0448704-T3 (DK)
Inventor: OPPERMANN HERMANN
IPC: A61K48/00
Filed: 1990-10-15
Granted: 1999-04-06
Abstract: Disclosed are 1) amino acid sequence data, structural features, and various other data characterizing a human osteogenic protein, OP1, 2) osteogenic devices comprising a heat treated xenogenic bone collagen matrix containing osteogenic protein, 3) methods of producing osteogenic proteins using recombinant DNA technology and 4) use of osteogenic devices to mimic the natural course of endochondral bone formation in mammals.
Patent DK-0523282-T3 (DK)
Inventor: NIEMANN HANS-DIETER
IPC: E06B3/54
Filed: 1991-10-18
Granted: 1996-08-12
Abstract: Supporting element which is essentially designed as a plate (10), the underside of which rests on a frame surface or similar support surface and the upper side (13) of which supports the glazing or the like, and has at least one convexity (16) which projects resiliently from the plate plane on the glass side and which in particular is orientated transversely to longitudinal edges (17) of the plate (10).   Adjoining the convexity (16) and facilitating its deformation is at least one slot-shaped or groove-shaped recess (20) of the plate (10).   <IMAGE>
Patent DK-0439428-T3 (DK)
Inventor: HAGMANN PETER DR
IPC: B23K26/082
Filed: 1991-01-15
Granted: 1995-05-22
Abstract: A process for the production of contact lenses, especially individually adapted contact lenses, and a contact lens preparation system for this, in which the topography of the eye surface is measured three-dimensionally, the geometry of the rear surface of the lens is determined for adaptation to the measured topography, the optical effect of a tear lens produced between the rear surface of the lens and the eye surface is determined, the geometry of the front face of the lens is established taking account of the optical effect of the tear lens and of the viewing correction to be achieved, and the data obtained in this way for the lens geometry at the front and rear surfaces of the lens are stored and transmitted to a control device for producing the lens in a processing machine. 
<IMAGE>
Patent DK-0536178-T3 (DK)
Inventor: GOTCH FRANCES MARGARET
IPC: G01N33/543
Filed: 1991-06-14
Granted: 1995-12-11
Abstract: PCT No. PCT/GB91/00963 Sec. 371 Date Feb. 26, 1993 Sec. 102(e) Date Feb. 26, 1993 PCT Filed Jun. 14, 1991 PCT Pub. No. WO92/00524 PCT Pub. Date Jan. 9, 1992.A method of detecting in a sample CTL specific for a particular virus, e.g. HIV, comprises contacting the sample with a support carrying immobilized antibodies to a surface antigen on T cells; separating the support and attached materials; contacting the separated support with target cells matched to the HLA type of the source of the sample and with HLA matched peptide epitope of the virus that interacts with the CTL of interest; and monitoring lysis of the target cells.
Patent DK-0549594-T3 (DK)
Inventor: GLUCHOWSKI CHARLES
IPC: C07D403/12
Filed: 1991-07-22
Granted: 1995-04-10
Abstract: A compound selected from the group consisting of those having the formula:   <IMAGE>   and pharmaceutically acceptable acid addition salts thereof, wherein R1 and R4 are independently selected from the group consisting of H and alkyl radicals having 1 to 4 carbon atoms; the R2s are each H or alkyl radicals having 1 to 4 carbon atoms or are, together, oxo; the R3s are each H or alkyl radicals having 1 to 4 carbon atoms or are, together, oxo, provided that the R2s or the R3s are alkyl radicals; the 2-imidazolin-2-ylamino group may be in any of the 5-, 6, 7- or 8-positions of the quinoxaline nucleus; and R5, R6 and R7 each is located in one of the remaining 5-, 6-, 7- or 8-positions of the quinoxaline nucleus and is independently selected from the group consisting of Cl, Br, H and alkyl radicals having 1 to 3 carbon atoms. Such compounds, when administered to a mammal, provide desired therapeutic effects, such as alteration in the rate of fluid transport in the gastrointestinal tract, reduction in intraocular pressure, and increase in renal fluid flow.
Patent DK-0552296-T3 (DK)
Inventor: PASTAN IRA H
IPC: A61P35/00
Filed: 1991-10-09
Granted: 1998-04-27
Abstract: The subject invention relates to monoclonal antibodies and uses thereof. In particular, the invention relates to three monoclonal antibodies, referred to as B1, B3, and B5, which are useful in the treatment and diagnosis of many forms of cancer.
Patent DK-0529793-T3 (DK)
Inventor: ASTBURY CHRISTOPER JOHN
IPC: C10G11/22
Filed: 1992-07-17
Granted: 1996-09-30
Abstract: A process for the production of mono-olefins from a paraffin-containing hydrocarbon feed having at least two carbon atoms which comprises a first step of partially combusting a mixture of the hydrocarbon feed and a molecular oxygen-containing gas in contact with a catalyst capable of supporting combustion beyond the normal fuel rich limit of flammability, the first step being carried out under a total pressure of greater than 5 bar absolute and at a temperature of greater than 650 DEG C; and a second step of cooling the mono-olefinic products to 600 DEG C or less within less than 50 milliseconds of formation.
Patent DK-0592573-T3 (DK)
Inventor: RING PETER
IPC: E04F15/02
Filed: 1992-06-29
Granted: 1996-09-30
Abstract: Bar pattern sheets having many parallel rows of bars, the bars in adjoining rows being mutually offset in the longitudinal direction, which sheets are used for production of a panel to be cut into a floor boards each containing b rows of bars. The pattern sheets comprise a x b rows of bars. The left end bars in each row being designated V1, V2, etc and the right end bars H1, H2 etc. The patterns on the left end bars and the right end bars with the same ordinal numbers for example V1 and H1 on at least one row of bars of each board match each other.
Patent DK-0605576-T3 (DK)
Inventor: POWELL BRIAN LESLIE
IPC: F02B75/02
Filed: 1992-09-23
Granted: 1997-06-16
Abstract: A two stroke internal combustion engine comprises a piston (8) reciprocating in compression chamber (6), an inlet valve (5) permitting the supply of scavenging air at high pressure to compression chamber (6), a small external combustion chamber (3) having restricted communication (9) with compression chamber (6), a valve (2) permitting the injection into combustion chamber (3) of a rich fuel/air mixture which in part passes to compression chamber (6) to form a fuel lean mixture with the scavenging air therein, and ignition means (1) to ignite the fuel which mixture in combustion chamber (3), in turn allowing burning fuel to ignite the fuel lean mixture in compression chamber (6) so that the operating temperatures in the compression chamber remain sufficiently low to inhibit the formation of nitrogen oxides therein.
Patent DK-0610309-T3 (DK)
Inventor: IRMSCHER LUTZ
IPC: E01B1/00
Filed: 1992-10-24
Granted: 1997-06-09
Abstract: In this device for capturing harmful substances with troughs (1) laid upon the roadbed (2) or other supports (3), with such a trough (1), the edge of the trough lying on the side of the trough (1) towards a rail (4) is constructed as a sealing edge (5) in such a way that it extends beneath the rail head (7). In order to stabilise the sealing edges (5) it is possible to provide supports (10) above which the sealing edges (5) can be supported on the rail foot (9). Securing webs (15) are provided to secure troughs (1.1) arranged at the side of a pair of rails to prevent the lateral slip of a trough (1.1). For the arrangement (1.2) between two rails (4) of a pair of rails, these troughs (1.2) are fitted with sealing edges (5) and fitted between the rails (4) in such a way that the sealing edges (5) are supported on either side of the rail webs (11).
Patent DK-0579996-T3 (DK)
Inventor: MUELLER HANS RUDOLF
IPC: A61K47/48
Filed: 1993-07-02
Granted: 1995-07-10
Abstract: The invention relates to cyclodextrin inclusion compounds of 5,10-methylenetetrahydrofolic acid. The surprisingly high stability of these compounds makes it possible to use them pharmaceutically for the first time. The invention also relates to a process for preparing the said substances and to their use for producing pharmaceutical compositions.
Patent DK-0640293-T3 (DK)
Inventor: ASKMAN LARS
IPC: A23L7/109
Filed: 1993-08-28
Granted: 1996-07-29
Abstract: A process for blanching or cooking a pasta strand which comprises feeding a pasta strand and hot water to the inlet of a pipe, conveying the pasta strand and hot water through the pipe for blanching or cooking the pasta strand, draining water from the blanched or cooked pasta strand as it exits from the pipe and recirculating the drained water to the inlet of the pipe. <IMAGE>
Patent DK-0649577-T3 (DK)
Inventor: JENSEN FINN
IPC: H02K29/03
Filed: 1993-07-02
Granted: 1996-10-07
Abstract: PCT No. PCT/DK93/00220 Sec. 371 Date Dec. 19, 1994 Sec. 102(e) Date Dec. 19, 1994 PCT Filed Jul. 2, 1993 PCT Pub. No. WO94/01919 PCT Pub. Date Jan. 20, 1994.A fault-tolerant reluctance motor has a multi-phase stator winding. The stator has a different number of poles from the rotor. The lead angle and the pole angle ( beta s,  beta r) embraced by each stator and rotor pole is at least the same as twice the step angle   <IMAGE>   where q is the number of phases and Nr is the number of rotor poles. In particular, the stator has ten poles, the rotor has six poles and the stator winding has five phases. Such a reluctance motor starts up from any motor position in one or other direction of rotation, even when one of the phase windings is completely or partially ineffective owing to a fault.
Patent DK-0647197-T3 (DK)
Inventor: BUECHELER HERBERT
IPC: B65D47/12
Filed: 1993-06-24
Granted: 1997-09-22
Abstract: The invention concerns a closure (2) for a container (1) for pourable materials, the container having a pour opening with a screw thread on to which the closure (2) is screwed. The aim of the invnetion is to enable a multiplicity of closure elements to be provided using a minimum of material. This is achieved by means of a first, screw-on, element (3) and a second, closure-cap, element (4, 4a) fixed without wastage to the screw-on element.
Patent DK-0655994-T3 (DK)
Inventor: TAPOLCZAY DAVID JOSZEF
IPC: C07B61/00
Filed: 1993-08-19
Granted: 1997-12-29
Abstract: PCT No. PCT/EP93/02219 Sec. 371 Date Apr. 6, 1995 Sec. 102(e) Date Apr. 6, 1995 PCT Filed Aug. 19, 1993 PCT Pub. No. WO94/04486 PCT Pub. Date Mar. 3, 1994A process is claimed for preparing [1S(1( alpha , 2 beta , 4 beta )]-4-amino-2-hydroxymethyl -1-cyclopentanol from cis-4-((R)-benzoylamino)-2-cyclopentenecarboxylic acid, methyl ester in five steps. The invention also describes a number of novel intermediates useful in the synthesis of [1S(1 alpha , 2 beta ,4 beta )]-4-amino-2-hydroxymethyl-1-cyclopentanol.
Patent DK-0690792-T3 (DK)
Inventor: FLUEGGE RUPRECHT
IPC: B41J13/26
Filed: 1994-03-11
Granted: 1997-03-10
Abstract: PCT No. PCT/DE94/00273 Sec. 371 Date Sep. 20, 1995 Sec. 102(e) Date Sep. 20, 1995 PCT Filed Mar. 11, 1994 PCT Pub. No. WO94/21466 PCT Pub. Date Sep. 29, 1994A recording substrate (21) is brought into a predetermined position on a recording substrate holder (10). One edge of the recording substrate (21) rests against a recording substrate stop (18) provided at one side on the recording substrate holder (10). Extending transversely to the recording substrate stop (18), in or on the recording substrate holder (10), there is a transmitting or receiving means (KS) which can be covered by the recording substrate (21). A receiving or transmitting means (KE) is provided on the printing head (7). In the region of the extent of the transmitting or recording means (KS), at a defined distance from the recording substrate stop (18), a shielding surface (30) is arranged on the recording substrate holder (10). During the movement of the printing head (7) along the transmitting or receiving means (KS), the location of the shielding surface (30) and the location of the recording substrate edge remote from the recording substrate stop (18) are detected.
Patent DK-0691978-T3 (DK)
Inventor: TEOULE ROBERT
IPC: C12Q1/6825
Filed: 1994-03-30
Granted: 1998-05-25
Abstract: A copolymer of general formula (I), wherein unit A is a monomer of an electronically conductive polymer, unit B is a nucleotide, an oligonucleotide or an analogue thereof, x, y, z are integers of 1 or higher or y is 0, and 1 is a covalent bond, or a spacer arm. Methods for preparing polymer (I) and its use, in particular for nucleic acid synthesis, sequencing and hybridization, are also disclosed.
Patent DK-0740531-T3 (DK)
Inventor: RYGAARD JORGEN A
IPC: A61B17/02
Filed: 1994-04-12
Granted: 2000-01-31
Abstract: PCT No. PCT/DK94/00148 Sec. 371 Date Aug. 22, 1996 Sec. 102(e) Date Aug. 22, 1996 PCT Filed Apr. 12, 1994 PCT Pub. No. WO95/17127 PCT Pub. Date Jun. 29, 1995A method of locating a constriction in a coronary artery and performing an arteriotomy distally thereof which comprises locating the site of a constriction in a coronary artery by scanning the artery with a non-invasive sensing instrument capable of detecting the constriction. The sensing instrument has associated therewith a cutting instrument comprised of a cutter and member for moving the cutter into a position for making an incision. After the constriction is located, the cutting member is moved into a cutting position distal of the constriction and an incision is made through the wall of the artery into the lumen thereof.
Patent DK-0707478-T3 (DK)
Inventor: SANTUS GIAN CARLO
IPC: A61P25/34
Filed: 1994-07-20
Granted: 2011-10-24
Abstract: A method for smoking cessation therapy is described that is utilizing an improved nicotine lozenge to satisfy transient craving. The lozenge contains nicotine, a non-nutritive sweetener and an absorbent excipient.
Patent DK-0737691-T3 (DK)
Inventor: KIM SUN HYUK
IPC: A61K38/00
Filed: 1995-03-13
Granted: 1999-06-07
Abstract: The invention features linear therapeutic peptides of the following formula: <CHEM> in which A<1> is a D- alpha -aromatic amino acid or a D- alpha -tethered amino acid; A<2> is Gln, His, 1-methyl-His, or 3-methyl-His; A<3> is the D- or L-isomer selected from Nal, Trp, Phe, and p-X-Phe, where X is F, Cl, Br, NO2, OH or CH3; A<4> is Ala, Val, Leu, Ile, Nle, or  alpha -aminobutyric acid; A<5> is Val, Ala, Leu, Ile, Nle, Thr, or  alpha -aminobutyric acid; A<6> is  beta -Ala; A<7> is His, 1-methyl-His, 3-methyl-His, Lys, or  epsilon -alkyl-Lys; A<8> is Leu, Ile, Val, Nle,  alpha -aminobutyric acid, Trp, Pro, Nal, Chx-Ala, Phe, or p-X-Phe, where X is F, Cl, Br, NO2, OH or CH3; A<9> is Met, Met-oxide, Leu, Ile, Nle,  alpha -aminobutyric acid, or Cys; each R1 and R2, independently, is H, C1-12 alkyl, C7-10 phenylalkyl, or COE1, where E1 is C1-20 alkyl, C3-20 alkenyl, C3-20 alkynyl, phenyl, 3,4-dihydroxyphenylalkyl, naphthyl, or C7-10 phenylalkyl; provided that when either R1 or R2 is COE1, the other must be H; and R3 is OH, NH2, C1-12 alkoxy, C7-10 phenylalkoxy, C11-20 naphthylalkoxy, C1-12 alkylamino, C7-10 phenylalkylamino, C11-20 naphthylalkylamino; or a pharmaceutically acceptable salt of such peptides. <IMAGE>
Patent DK-0776246-T3 (DK)
Inventor: HAYDEN RICHARD A
IPC: B01J37/06
Filed: 1995-03-29
Granted: 1999-11-29
Abstract: A process is provided for the restoration of hydrogen sulfide removal capacity in nitrogen-treated carbonaceous chars which have become exhausted for hydrogen sulfide capacity when used for the removal of hydrogen sulfide from gas streams containing oxygen and water. This process entails washing the spent carbonaceous char with water of sufficient quantity to remove the majority of the hydrogen sulfide reaction products. By the use of this process a significant proportion of the original hydrogen sulfide capacity of the nitrogen-treated carbonaceous char is recovered.